Innovations in Vaccine Adjuvants and Immune Modulation

Moderator(s)

• TC

  Theresa Chang, PhD

  Professor
  Public Health Research Institute
  Rutgers New Jersey Medical School
  Montclair, New Jersey, United States
• 

  Michael Cho, PhD

  Professor
  Iowa State Univ.

Presentations:

• 9:45 AM - 10:00 AM US ET

  A novel double-stranded RNA adjuvant markedly amplifies the immunogenicity of nucleoside-modified mRNA-LNP vaccines
  

  Author: Fernanda C. Coirada, PhD (she/her/hers) – University of Pennsylvania
• 10:00 AM - 10:15 AM US ET

  Bioactive Enhanced Adjuvant Chemokine Oligonucleotide Nanoparticles (BEACON) for Mucosal Vaccination Against Genital Herpes
  

  Author: Sachin Bhagchandani, PhD – Yale School of Medicine
• 10:15 AM - 10:30 AM US ET

  IL-15 induces durable resident memory T cell formation and function following genetically attenuated Plasmodium vaccination in mice
  

  Author: Rizwan M. Mahmud, MS (he/him/his) – University of Minnesota, Twin Cities
• 10:30 AM - 10:45 AM US ET

  Optimizing T Cell Priming Using TLR4/9 Combination Adjuvant For Robust Cell-Mediated Immunity Against Influenza
  

  Author: Dan Nguyen (she/her/hers) – Univ. of California, Irvine
• 10:45 AM - 11:00 AM US ET

  The roles of Type I interferon subtypes and signaling in mRNA lipid nanoparticle vaccine-induced CD8 T-cell protective immunity.
  

  Author: Samita Kafle, PhD (she/her/hers) – Thomas Jefferson Univ.
• 11:00 AM - 11:15 AM US ET

  Type 1 Interferon Restricts mRNA Vaccine Efficacy Through Suppression of Antigen Uptake in Conventional Dendritic Cells
  

  Author: Tyson Lobb – Saint Louis University School of Medicine